Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate–pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P -glycoprotein
Future Medicinal Chemistry · 02.01.2026 · 18 (1) · 67-78
DOI: 10.1080/17568919.2025.2602963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 13.12.2025. Verfasst von Mirjana Mosić und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: Quantitative Structure-Activity Relationship, Pyrimidines, Antineoplastic Agents, Artesunate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia.
Abstract (Originalsprache)
AIMS: To evaluate chromatographic lipophilicity of novel artesunate-pyrimidine hybrids and precursors using reversed-phase thin-layer chromatography (RP-TLC) and assess plasma protein binding (PPB). The impact of measured and predicted lipophilicity on pharmacokinetic descriptors was evaluated. Principal component analysis (PCA) explored relationships among lipophilicity, PPB, and physicochemical descriptors. Quantitative structure-activity relationship (QSAR) and partial least squares (PLS) models linked molecular descriptors to cytotoxicity and resistance modulation in nonsmall cell lung cancer (NSCLC) cells. MATERIALS AND METHODS: Lipophilicity was measured by RP-TLC. PPB was determined using human serum albumin (HSA)-modified high-performance liquid chromatography (HPLC). PCA characterized physicochemical-pharmacokinetic correlations. Cytotoxicity in sensitive NCI-H460 and multidrug-resistant (MDR) NCI-H460/R cells was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. QSAR and PLS models identified key descriptors. RESULTS: Lipophilicity strongly influenced adsorption, distribution, and protein binding. Highly lipophilic hybrids showed near-complete HSA binding. Compound 2k lost cytotoxicity in the presence of albumin, whereas 4k retained potency. Models indicated steric and electronic features, alongside lipophilicity, dictate efficacy and P-glycoprotein (P-gp) interactions, particularly in resistant cells. CONCLUSIONS: Lipophilicity and steric/electronic descriptors govern distribution, protein binding, and anticancer activity. Integrating these features enables design of hybrids overcoming P-gp-mediated multidrug resistance, with hybrid 4k emerging as a promising candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, University of Belgrade, Belgrade, Serbia.
- Department of Organic Chemistry, Innovative Centre, Faculty of Chemistry, Ltd., Belgrade, Serbia.
- Department of Neurobiology, Institute for Biological Research "Siniša Stanković"- National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
- Institute of Chemistry, Technology and Metallurgy, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
ORCID-Profile: Mirjana Mosić, Ljiljana Koračak, Marija Grozdanić, Nataša Terzić Jovanović, Milica Pešić, Sandra Šegan
Förderung
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
Zitieren
APA
Mosić, M., Koračak, L., Grozdanić, M., Jovanović, N. T., Pešić, M., & Šegan, S. (2026). Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate–pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P -glycoprotein. Future Medicinal Chemistry, 18(1), 67-78. https://doi.org/10.1080/17568919.2025.2602963
Vancouver
Mosić M, Koračak L, Grozdanić M, Jovanović NT, Pešić M, Šegan S. Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate–pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P -glycoprotein. Future Medicinal Chemistry. 2026;18(1):67-78. doi:10.1080/17568919.2025.2602963
BibTeX
@article{Mosi2026,
author = {Mosić, Mirjana and Koračak, Ljiljana and Grozdanić, Marija and Jovanović, Nataša Terzić and Pešić, Milica and Šegan, Sandra},
title = {Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate–pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P -glycoprotein},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {1},
pages = {67--78},
doi = {10.1080/17568919.2025.2602963}
}
EUVIMED